PIXLUMI
LIVE

Serial Number

79428134

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Jun 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PIXLUMI Trademark

Serial Number: 79428134

PIXLUMI is a trademark filed by Telix Pharmaceuticals Limited on June 4, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

June 4, 2025

Registration Date

Not Registered

Published for Opposition

June 2, 2026

Goods & Services

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2026 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
REFUSAL PROCESSED BY IB
Nov 7, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 20, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 20, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 1, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 30, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 17, 2025 REPR